SMX’s second invitation from NAFRA signals a shift from proof to recognition NEW YORK, NY / ACCESS Newswire / December 10, 2025 / When an industry organization invites a company into the room, it’s a ...
First disclosure of PRT12396, a JAK2V617F-selective JH2 inhibitor demonstrates disease modifying potential in myeloproliferative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback